| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| DEMARCO ERIC M | President & CEO, Director | 10680 TREENA STREET, SUITE 600, SAN DIEGO | Eric M. DeMarco, by Eva Yee, Attorney-In-Fact | 2025-12-03 | 0001082440 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | KTOS | Common Stock | Sale | -$5.74M | -78.1K | -5.59% | $73.46 | 1.32M | Dec 1, 2025 | by trust | F1, F3 |
| transaction | KTOS | Common Stock | Sale | -$8.12M | -109K | -8.29% | $74.35 | 1.21M | Dec 1, 2025 | by trust | F1, F4 |
| transaction | KTOS | Common Stock | Sale | -$557K | -7.41K | -0.61% | $75.20 | 1.2M | Dec 1, 2025 | by trust | F1, F5 |
| transaction | KTOS | Common Stock | Sale | -$397K | -5.2K | -0.43% | $76.40 | 1.2M | Dec 1, 2025 | by trust | F1, F6 |
| transaction | KTOS | Common Stock | Sale | -$8.49M | -119K | -9.93% | $71.45 | 1.08M | Dec 2, 2025 | by trust | F2, F7 |
| transaction | KTOS | Common Stock | Sale | -$3.45M | -47.8K | -4.43% | $72.30 | 1.03M | Dec 2, 2025 | by trust | F2, F8 |
| transaction | KTOS | Common Stock | Sale | -$1.99M | -27K | -2.63% | $73.51 | 1M | Dec 2, 2025 | by trust | F2, F9 |
| transaction | KTOS | Common Stock | Sale | -$474K | -6.4K | -0.64% | $74.12 | 996K | Dec 2, 2025 | by trust | F2, F10, F12 |
| holding | KTOS | Common Stock | 62K | Dec 1, 2025 | Direct | F11, F12 |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
| Id | Content |
|---|---|
| F1 | This transaction was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on August 29, 2025. |
| F2 | Open market sale of Issuer's common stock made in accordance with Issuer's trading policies. |
| F3 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $73.04 to $74.035 inclusive. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. |
| F4 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $74.04 to $75.03 inclusive. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. |
| F5 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.04 to $75.61 inclusive. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. |
| F6 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $76.35 to $76.40 inclusive. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. |
| F7 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.90 to $71.89 inclusive. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. |
| F8 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $71.90 to $72.89 inclusive. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. |
| F9 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $72.90 to $73.88 inclusive. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. |
| F10 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $73.90 to $74.42 inclusive. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. |
| F11 | Includes 43,384 shares purchased through Issuer's Employee Stock Purchase Plan and approximately 18,576 shares held through Issuer's 401(k) Plan. |
| F12 | In addition, as of December 2, 2025, 1,212,500 deferred restricted stock units (RSUs) granted to Mr. DeMarco, representing non-qualified deferred compensation, have vested but remain subject to a previously agree to 5-year deferral period before issuance and release, which substantially all subject RSUs are scheduled to be released by January 2029, and an additional 750,000 RSUs granted to Mr. DeMarco are currently unvested and will only vest upon achievement of applicable vesting terms described in our proxy statement on Schedule 14A filed with the SEC on April 4, 2025. Each RSU represents a contingent right to receive one share of the Company's common stock. |